Skip to main content

Peer Review reports

From: Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

Original Submission
17 Jun 2021 Submitted Original manuscript
22 Jul 2021 Author responded Author comments - Jesper Østrup Rasmussen
Resubmission - Version 2
22 Jul 2021 Submitted Manuscript version 2
26 Jul 2021 Editorially accepted
14 Aug 2021 Article published 10.1186/s12888-021-03395-9

You can find further information about peer review here.

Back to article page